We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical Gains on Cost-Cut Actions Amid Weak Demand
Read MoreHide Full Article
We issued an updated research report on Eastman Chemical Company (EMN - Free Report) on July 15.
The company's cost management actions and growth in high-margin innovation products are expected to contribute to its earnings in 2020. Eastman Chemical is taking an aggressive approach to manage cost in a challenging environment. In response to the coronavirus pandemic, the company raised its cost-reduction target, which is projected to be around $150 million of net savings in 2020. These cost-cut actions include reduction of discretionary spending.
Eastman Chemical is also focused on growing new business revenues through innovation. The company expects to generate around $500 million of new business revenues in 2020. Especially, the company’s Advanced Materials unit has a number of products that are driving new business revenues.
The company is also undertaking actions to boost its cash flows, including the reduction of capital expenditures by around $100 million to $325-375 million. It also expects working capital to be a source of more than $250 million of cash flows this year. Eastman Chemical also expects to reduce debt by more than $400 million in 2020.
However, the company is witnessing weaker demand across certain markets. Lower demand in transportation and textile markets in the first quarter due to the pandemic affected volumes in these markets. Further, Eastman Chemical envisions greater challenges in transportation, textiles and energy markets in the second quarter. As such, sales volumes are expected to remain under pressure in the second quarter. Also, the company has withdrawn its guidance for 2020 due to uncertainties surrounding the pandemic.
Shares of Eastman Chemical have lost 3.5% in the past year compared with 8.6% decline of its industry.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Sandstorm Gold has an expected earnings growth rate of 55.6% for 2020. The company’s shares have surged 65.3% in the past year.
Harmony Gold has an expected earnings growth rate of 264.3% for fiscal 2020. Its shares have returned 147.9% in the past year.
Northern Dynasty has an expected earnings growth rate of 28.6% for 2020. The company’s shares have skyrocketed 207.5% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Eastman Chemical Gains on Cost-Cut Actions Amid Weak Demand
We issued an updated research report on Eastman Chemical Company (EMN - Free Report) on July 15.
The company's cost management actions and growth in high-margin innovation products are expected to contribute to its earnings in 2020. Eastman Chemical is taking an aggressive approach to manage cost in a challenging environment. In response to the coronavirus pandemic, the company raised its cost-reduction target, which is projected to be around $150 million of net savings in 2020. These cost-cut actions include reduction of discretionary spending.
Eastman Chemical is also focused on growing new business revenues through innovation. The company expects to generate around $500 million of new business revenues in 2020. Especially, the company’s Advanced Materials unit has a number of products that are driving new business revenues.
The company is also undertaking actions to boost its cash flows, including the reduction of capital expenditures by around $100 million to $325-375 million. It also expects working capital to be a source of more than $250 million of cash flows this year. Eastman Chemical also expects to reduce debt by more than $400 million in 2020.
However, the company is witnessing weaker demand across certain markets. Lower demand in transportation and textile markets in the first quarter due to the pandemic affected volumes in these markets. Further, Eastman Chemical envisions greater challenges in transportation, textiles and energy markets in the second quarter. As such, sales volumes are expected to remain under pressure in the second quarter. Also, the company has withdrawn its guidance for 2020 due to uncertainties surrounding the pandemic.
Shares of Eastman Chemical have lost 3.5% in the past year compared with 8.6% decline of its industry.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space include Sandstorm Gold Ltd. (SAND - Free Report) , Harmony Gold Mining Company Limited (HMY - Free Report) and Northern Dynasty Minerals Ltd. (NAK - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Sandstorm Gold has an expected earnings growth rate of 55.6% for 2020. The company’s shares have surged 65.3% in the past year.
Harmony Gold has an expected earnings growth rate of 264.3% for fiscal 2020. Its shares have returned 147.9% in the past year.
Northern Dynasty has an expected earnings growth rate of 28.6% for 2020. The company’s shares have skyrocketed 207.5% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>